ArticleCureus2025
Radiotherapy for Symptomatic Knuckle Pads Associated With Dupuytren's Disease: A Report of a Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeKnuckle pads are often diagnosed in patients with palmar fibromatosis or Dupuytren's disease. At present, no widely accepted treatment for knuckle pads has been established. Here, we describe the outcomes of patients with knuckle pads treated with radiotherapy at our institution. MATERIALS AND
methodsPatients who had received radiotherapy for knuckle pads since 2012 and completed questionnaires at the time of consultation and at follow-up interview are included in this longitudinal analysis. We report patient characteristics, treatment plans, patient-reported knuckle pad response to radiotherapy, and patient satisfaction.
resultsNine Caucasian patients, median age 56 years old (range, 42-63), including seven women and two men, completed radiotherapy to their knuckle pads. Eight patients received simultaneous radiotherapy to the palms, and two patients additionally received radiotherapy to the soles. The time since treatment varied from 3 to 12 years, with a median duration of nine years. Typical treatment included a split-course prescription to 30 Gy in 10 daily fractions with a 6-12-week mid-treatment break. Electron beam energy was typically 6 MeV prescribed to the 90%-100% isodose line using a 1-1.5 cm bolus. Following radiotherapy, seven out of nine (78%) patients reported either resolution, flattening of knuckle pads, or stable disease. One patient (11%) reported resolution of knuckle pads in one hand, but enlargement and the development of new knuckle pads in the other hand. One patient (11%) reported worsening disease with enlargement of knuckle pads wrapping around the fingers toward the palmar aspect. Regarding symptomatic treatment response, eight patients (89%) reported improved symptoms or symptom resolution since radiotherapy including improvement in tenderness and pain, one (11%) reported stable symptoms. Minimal acute and chronic toxicity was reported. Eight patients (89%) reported favorable outcomes.
conclusionsOur study details the treatment response of nine patients with knuckle pads to radiotherapy. Patients tolerated treatment well, with the majority reporting symptomatic and physical improvement, as well as favorable satisfaction with outcomes. Our findings suggest that radiotherapy is a safe and effective treatment option for knuckle pads providing durable disease control and can be considered in the appropriate clinical setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.